Cart
0
The question of how often to get eyes tested does not have a single universal answer — the appropriate interval depends on age, health profile, risk factors, and whether the prescription has been stable or changing. What is consistent across all of these variables is that most people test their eyes less frequently than is clinically appropriate, often waiting until their vision has noticeably worsened or their glasses have become clearly inadequate before booking an examination. This guide covers the recommended testing intervals for different age groups and health profiles, why those intervals exist, and what is missed when examinations are delayed beyond them.
Eye Test Frequency: Recommended Intervals by Profile
| Profile | Recommended Interval | Primary Reason | What Is Checked |
|---|---|---|---|
| Children under 5 | At least once before starting school; earlier if parents notice any sign of squinting, eye turn, or visual difficulty | Amblyopia (lazy eye) and strabismus detection — conditions that are highly treatable in early childhood and increasingly difficult to treat after age 7–8 | Visual acuity in each eye, eye alignment, binocular function, refractive error |
| School-age children (5–18) | Every year, or immediately if academic performance, reading, or board-viewing difficulty is noticed | Myopia in Indian children progresses rapidly during school years — annual testing catches prescription changes before they significantly affect academic performance; myopia management is most effective when initiated early | Prescription update, myopia progression rate, binocular vision, eye health |
| Young adults (18–40), healthy, stable prescription | Every 2 years | Prescription stability monitoring; baseline ocular health documentation while conditions are most likely absent and any findings are most meaningful as baseline data | Prescription update, intraocular pressure screening, basic ocular health |
| Young adults (18–40), changing prescription | Every year until stability is established | A prescription that changes by more than 0.50 dioptres per year indicates ongoing refractive change — annual testing ensures the correction remains current and identifies whether myopia progression continues | Prescription update, progression rate assessment |
| Adults over 40 | Every year | Presbyopia onset and progression requires annual near addition assessment; glaucoma, macular degeneration, and cataract risk all increase from this age and benefit from annual monitoring | Full prescription including near addition, intraocular pressure, fundus examination, anterior eye health |
| Adults with diabetes | Every year minimum — more frequently if retinopathy is already present | Diabetic retinopathy causes permanent vision loss before producing noticeable symptoms; annual fundus examination is the primary tool for detecting and monitoring it in the treatable stage | Fundus examination for diabetic retinopathy, macular assessment, full prescription |
| Adults with family history of glaucoma | Every year from age 40; every 2 years from age 30 if strong family history | First-degree family history of glaucoma is a major risk factor; annual monitoring of intraocular pressure, optic nerve, and visual fields allows detection before significant vision loss occurs | Intraocular pressure, optic nerve assessment, visual field testing, full prescription |
| Anyone with new visual symptoms | Immediately — do not wait for the next scheduled examination | Sudden onset of floaters, flashes, curtain effects, double vision, sudden vision loss, or significant change in visual quality can indicate conditions requiring urgent assessment | Full examination directed by the presenting symptom |
Key Points at a Glance
- The most common reason people delay eye tests is the absence of noticeable symptoms — but many of the conditions that eye examinations detect, including glaucoma, diabetic retinopathy, and early macular degeneration, produce no noticeable symptoms until significant and sometimes irreversible damage has occurred; the interval recommendation exists precisely because waiting for symptoms is waiting too long
- Children's eye tests are the most time-sensitive — amblyopia treated before age 7 has a high success rate; amblyopia detected after age 10 is significantly harder to treat and may result in permanent reduced vision in the affected eye; annual testing through school years is the appropriate cadence for Indian children given the rapid myopia progression common in this population
- Adults over 40 should treat annual eye examinations as a health maintenance routine comparable to annual blood pressure checks — the examination is not only about updating the glasses prescription but about monitoring the ocular health changes that become more common and consequential from this age
- India's high and rising prevalence of diabetes makes annual fundus examination for diabetic retinopathy a priority for a large proportion of the adult Indian population — the condition is the leading cause of preventable blindness in working-age Indians and is detectable and treatable in its early stages
- A prescription that felt adequate a year ago may have changed enough to cause eye strain, headaches, or reduced visual performance without the change being obvious — annual or biennial prescription checks maintain the correction at the level the eyes currently need rather than the level they needed two or three years ago
- Contact lens wearers should be examined annually regardless of prescription stability — the ocular health monitoring associated with contact lens wear is an additional reason for annual examination beyond the prescription update
- The interval recommendations are minimum frequencies — wearers with active prescription changes, new symptoms, or monitored conditions should be examined more frequently as clinically directed
The Complete Guide: How Often Should You Get Your Eyes Tested?
Why Waiting for Symptoms Is the Wrong Approach
The most common reason people delay eye examinations beyond the appropriate interval is the absence of noticeable symptoms — the implicit logic being that if vision seems adequate, no examination is needed. This logic is reliable for some health conditions and unreliable for eye health specifically, because several of the most clinically significant conditions that eye examinations detect are asymptomatic in their early and most treatable stages.
Glaucoma — the progressive loss of peripheral vision caused by optic nerve damage — typically produces no symptoms until a substantial proportion of peripheral vision has been lost. The optic nerve fibres damaged by glaucoma do not regenerate, and the vision loss is permanent. By the time a person notices their peripheral vision is reduced, the condition has often been progressing for years. The examination interval recommendations for adults over 40 and for those with family history of glaucoma exist specifically to detect the condition in the stage before it produces noticeable symptoms — the stage at which treatment can prevent further progression rather than trying to manage a condition already advanced.
Diabetic retinopathy follows the same pattern — it causes no noticeable visual symptoms in its non-proliferative early stages, during which laser treatment and other interventions can preserve vision effectively. By the time it causes blurred vision or floaters, it has typically progressed to a stage where treatment is more difficult and the visual outcome less favourable. Annual fundus examination for diabetic wearers is the tool that catches the condition in the treatable window, not after it has declared itself through symptoms.
Even for conditions less immediately threatening than glaucoma and diabetic retinopathy, the absence of noticeable symptoms does not mean the prescription is still optimal. A prescription that has changed by 0.50 to 0.75 dioptres — a clinically meaningful change — may not be noticed by the wearer as blurriness but will produce increased eye strain, headache with sustained near work, and reduced visual performance, particularly at the end of the day when the eyes are fatigued. Waiting until vision is obviously blurry is waiting until the prescription has changed by more than the amount that was already causing fatigue and reduced performance.
Children: The Most Time-Sensitive Testing Schedule
Eye testing in children is more time-sensitive than at any other life stage because the visual system is still developing and because certain conditions — particularly amblyopia — are significantly easier to treat during the developmental window than after it closes.
Amblyopia, commonly called lazy eye, is a condition in which one eye does not develop normal visual acuity despite having no structural problem with the eye itself — the reduced acuity is a developmental outcome of the brain favouring the other eye during the critical period of visual development. Amblyopia affects approximately 2 to 3 percent of children and is the most common cause of monocular vision impairment in children and young adults. Treatment — typically patching the stronger eye to force the brain to use the weaker one — is highly effective before the age of 7 and progressively less effective after that age, with limited benefit after age 10 in most cases. A child whose amblyopia is not detected before age 7 may have permanently reduced vision in the affected eye that could have been fully corrected with earlier treatment.
Amblyopia is not detectable by casual observation in many cases — the child may appear to see normally because the brain suppresses the weaker eye's input rather than signalling a problem. Only an eye examination that tests each eye separately can detect the acuity difference. This is why a pre-school examination before age 5 is recommended regardless of whether parents have noticed any visual difficulty — the condition the examination is designed to catch does not announce itself through obvious symptoms.
For school-age Indian children, myopia is an additional reason for annual testing throughout the school years. India is experiencing a myopia epidemic — the prevalence of myopia in Indian urban children has risen dramatically over recent decades, driven by reduced outdoor time, increased near work, and educational intensity. Myopia in children progresses faster than in adults, and in children with rapid progression, the prescription can change significantly within a single academic year. Annual testing identifies the rate of progression, allows myopia management strategies to be considered and implemented, and ensures the prescription remains current enough to support academic performance without eye strain.
The Over-40 Transition: Why Annual Becomes the Right Interval
The shift from biennial to annual examination at age 40 reflects a genuine change in the clinical picture rather than an arbitrary age-based rule. Two things happen in the eye around this age that make annual monitoring clinically meaningful: presbyopia begins, changing the near vision correction needed; and the risk of age-related ocular conditions — glaucoma, macular degeneration, cataracts — starts to increase in a way that makes annual screening beneficial.
Presbyopia — the age-related loss of the eye's ability to focus at near distances — begins for most people in their early to mid 40s and progresses throughout the 40s and 50s. The near addition required for comfortable reading and near work changes annually during this period — a 45-year-old typically needs a different near addition from a 48-year-old, and a glasses specification that was comfortable for reading at 44 will cause increasing near vision difficulty at 47 without an update. Annual examination during the presbyopic years ensures the near correction is updated at the rate the eye's focusing ability is changing, rather than allowing accumulated inadequacy to build into significant near vision difficulty.
Glaucoma risk increases from the age of 40 in the general population and is elevated by family history, Indian ethnicity, elevated intraocular pressure, and certain systemic conditions including diabetes and hypertension. Annual intraocular pressure measurement, optic nerve assessment, and visual field testing from age 40 provides the baseline and the monitoring frequency that allows early detection. The optic nerve changes of early glaucoma are subtle and develop slowly — detecting them requires the comparison of sequential measurements over time, which annual examination provides and which less frequent examination cannot.
Age-related macular degeneration — a leading cause of severe vision loss in adults over 50 — also benefits from early detection through annual fundus examination. The dry form of the condition progresses slowly and may be managed with nutritional intervention and lifestyle modification when detected early; the wet form, while progressing rapidly, responds well to intravitreal injection treatment when initiated promptly. Annual fundus examination provides the detection frequency needed to catch either form at the stage where intervention is most effective.
The Indian Diabetes and Eye Health Context
India's status as a country with one of the world's largest diabetic populations — with tens of millions of people with diabetes and a large additional population with undiagnosed diabetes — gives the annual eye examination recommendation for diabetic wearers specific weight in the Indian context. Diabetic retinopathy affects approximately one-third of people with diabetes globally, and in India the combination of high diabetes prevalence, long disease duration, and variable glycaemic control makes the retinopathy burden substantial.
The clinical case for annual fundus examination in diabetic Indian wearers is direct: diabetic retinopathy is detectable by fundus examination in its non-proliferative stages before it causes symptoms; treatment at this stage — laser photocoagulation, anti-VEGF injection, or vitrectomy depending on the severity — is effective at preserving vision; and without annual examination the condition progresses asymptomatically to a stage where vision loss has already occurred and treatment is managing damage rather than preventing it. The question of how often a diabetic Indian glasses wearer should get their eyes tested has a clear answer: annually at minimum, and more frequently if retinopathy has already been detected.
The additional consideration for Indian wearers is undiagnosed diabetes — a significant proportion of Indian adults with diabetes are undiagnosed because they have not had blood glucose testing. For wearers over 40 with risk factors for diabetes — family history, overweight, sedentary lifestyle — the annual eye examination that includes fundus assessment is one point in the healthcare system where undiagnosed diabetic changes in the retina might be detected and lead to the diabetes diagnosis that initiates systemic management.
Prescription Stability and the Testing Interval
For wearers whose primary concern is keeping their glasses prescription current rather than ocular health monitoring, the testing interval is governed by the rate of prescription change. A stable prescription — one that has not changed significantly over two or more consecutive annual examinations — supports moving to biennial testing for the prescription update component, provided the ocular health components are covered at appropriate intervals.
A changing prescription warrants annual testing until stability is established. This is most relevant for young people with progressing myopia, adults in the presbyopic years where near addition changes annually, and any wearer following a systemic condition or medication change that affects the refractive state. For these wearers, annual testing ensures the prescription is current rather than one or two changes behind the actual refractive state.
The practical consequence of wearing an under-corrected prescription is not simply slightly blurred vision. It is sustained eye muscle overwork as the eyes attempt to compensate for the inadequate correction, producing fatigue, headache, and reduced sustained performance at the visual tasks of daily professional and academic life. Maintaining a current prescription is a performance consideration as much as a vision quality one.
ELUNO's team at ELUNO stores can advise on the lens specification appropriate for the current prescription — including the index, coating, and progressive design most suitable for the prescription level and daily visual demands — once a current prescription from a qualified optometrist or ophthalmologist is in hand. The lens guide covers the full specification range for different prescription types and age profiles.
Final Thought
The right interval for eye testing is not determined by when vision becomes obviously inadequate — it is determined by the age, health profile, and risk factors that govern when clinically important changes are most likely to occur and most important to detect. For most adults, this means biennial testing through the stable years of early adulthood, transitioning to annual testing from age 40 or earlier for those with diabetes, family history of eye disease, or active prescription changes. For children, it means annual testing through the school years and pre-school testing before the developmental window for amblyopia treatment closes. The examination interval is the health maintenance decision that determines whether conditions are found at the stage where they can be managed effectively — or at the stage where they have already caused the damage the examination was intended to prevent.
